Absorption |
Blood-Brain Barrier | BBB+ | 0.9658 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.5708 |
P-glycoprotein Substrate | Substrate | 0.8181 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8986 |
Non-inhibitor | 0.8667 |
Renal Organic Cation Transporter | Non-inhibitor | 0.5443 |
Distribution |
Subcellular localization | Mitochondria | 0.5404 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7403 |
CYP450 2D6 Substrate | Substrate | 0.7978 |
CYP450 3A4 Substrate | Substrate | 0.6337 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6968 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8046 |
CYP450 2D6 Inhibitor | Inhibitor | 0.5448 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6053 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7754 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5158 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8642 |
Non-inhibitor | 0.6634 |
AMES Toxicity | Non AMES toxic | 0.7001 |
Carcinogens | Non-carcinogens | 0.9383 |
Fish Toxicity | High FHMT | 0.7583 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9765 |
Honey Bee Toxicity | Low HBT | 0.5199 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | II | 0.4449 |
Carcinogenicity (Three-class) | Non-required | 0.5315 |